Nancy Hunter
About
In The Last Decade
Nancy Hunter
122 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 135
- Oncology 2.7k
- Molecular Biology 2.0k
- Pulmonary and Respiratory Medicine 1.7k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Cancer Research 1.1k
Countries citing papers authored by Nancy Hunter
This map shows the geographic impact of Nancy Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hunter more than expected).
Fields of papers citing papers by Nancy Hunter
This network shows the impact of papers produced by Nancy Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hunter. The network helps show where Nancy Hunter may publish in the future.
Co-authorship network of co-authors of Nancy Hunter
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Hunter. A scholar is included among the top collaborators of Nancy Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Hunter. Nancy Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 42 | |
| 2 | 19 | |
| 3 | 49 | |
| 4 | [Recent studies on anti-angiogenesis in cancer therapy]. | 2 |
| 5 | Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. | 232 |
| 6 | Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. | 86 |
| 7 | In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. | 408 |
| 8 | 2 | |
| 9 | Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. | 102 |
| 10 | 5 | |
| 11 | 9 | |
| 12 | Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. | 272 |
| 13 | 33 | |
| 14 | 157 | |
| 15 | 45 | |
| 16 | 41 | |
| 17 | 25 | |
| 18 | 18 | |
| 19 | 14 | |
| 20 | Combination of Local Irradiation with Systemic Application of Anaerobic Corynebacteria in Therapy of a Murine Fibrosarcoma | 39 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.